These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 15805178)

  • 1. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.
    Murphy TF; Brauer AL; Grant BJ; Sethi S
    Am J Respir Crit Care Med; 2005 Jul; 172(2):195-9. PubMed ID: 15805178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum and mucosal antibody responses to outer membrane protein G1b of Moraxella catarrhalis in chronic obstructive pulmonary disease.
    Adlowitz DG; Kirkham C; Sethi S; Murphy TF
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):139-46. PubMed ID: 16420607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.
    Murphy TF; Brauer AL; Aebi C; Sethi S
    Infect Immun; 2005 Dec; 73(12):8161-6. PubMed ID: 16299311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.
    Parameswaran GI; Wrona CT; Murphy TF; Sethi S
    BMC Infect Dis; 2009 Nov; 9():178. PubMed ID: 19912665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Sethi R; Eschberger K; Lobbins P; Cai X; Grant BJ; Murphy TF
    Am J Respir Crit Care Med; 2007 Aug; 176(4):356-61. PubMed ID: 17478618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum
    George LM; Haigh RD; Mistry V; Haldar K; Barer MR; Oggioni MR; Brightling CE
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3663-3667. PubMed ID: 30510409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Evans N; Grant BJ; Murphy TF
    N Engl J Med; 2002 Aug; 347(7):465-71. PubMed ID: 12181400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease.
    Bakri F; Brauer AL; Sethi S; Murphy TF
    J Infect Dis; 2002 Mar; 185(5):632-40. PubMed ID: 11865420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.
    Adlowitz DG; Sethi S; Cullen P; Adler B; Murphy TF
    Infect Immun; 2005 Oct; 73(10):6601-7. PubMed ID: 16177336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease.
    Desai H; Eschberger K; Wrona C; Grove L; Agrawal A; Grant B; Yin J; Parameswaran GI; Murphy T; Sethi S
    Ann Am Thorac Soc; 2014 Mar; 11(3):303-9. PubMed ID: 24423399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.
    Ruckdeschel EA; Kirkham C; Lesse AJ; Hu Z; Murphy TF
    Infect Immun; 2008 Apr; 76(4):1599-607. PubMed ID: 18227159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.
    Parameswaran GI; Sethi S; Murphy TF
    Chest; 2011 Sep; 140(3):611-617. PubMed ID: 21349930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2.
    Tan TT; Forsgren A; Riesbeck K
    J Infect Dis; 2006 Aug; 194(4):493-7. PubMed ID: 16845633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N; Cheong YM; Tahir HM
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
    Murphy TF; Brauer AL; Eschberger K; Lobbins P; Grove L; Cai X; Sethi S
    Am J Respir Crit Care Med; 2008 Apr; 177(8):853-60. PubMed ID: 18202344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.
    Murphy TF; Brauer AL; Aebi C; Sethi S
    Infect Immun; 2005 Jun; 73(6):3471-8. PubMed ID: 15908376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moraxella catarrhalis, a human respiratory tract pathogen.
    Murphy TF; Parameswaran GI
    Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.
    Blakeway LV; Tan A; Peak IRA; Seib KL
    Microbiology (Reading); 2017 Oct; 163(10):1371-1384. PubMed ID: 28893369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and regulation of Moraxella catarrhalis-induced human beta-defensin 3 expression in human pulmonary epithelial cells.
    Haarmann H; Steiner T; Schreiber F; Heinrich A; Zweigner J; N'Guessan PD; Slevogt H
    Biochem Biophys Res Commun; 2015 Nov; 467(1):46-52. PubMed ID: 26417692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis.
    LaFontaine ER; Snipes LE; Bullard B; Brauer AL; Sethi S; Murphy TF
    Clin Vaccine Immunol; 2009 May; 16(5):653-9. PubMed ID: 19321697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.